Page last updated: 2024-09-05

succinobucol and tolbutamide

succinobucol has been researched along with tolbutamide in 1 studies

Compound Research Comparison

Studies
(succinobucol)
Trials
(succinobucol)
Recent Studies (post-2010)
(succinobucol)
Studies
(tolbutamide)
Trials
(tolbutamide)
Recent Studies (post-2010) (tolbutamide)
535165,368238265

Protein Interaction Comparison

ProteinTaxonomysuccinobucol (IC50)tolbutamide (IC50)
Cytochrome P450 2C9 Homo sapiens (human)0.392

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carter, JD; Cole, BK; Crim, WS; Kunsch, C; Mirmira, RG; Nadler, JL; Nunemaker, CS; Trace, AP; Wu, R1

Other Studies

1 other study(ies) available for succinobucol and tolbutamide

ArticleYear
AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets.
    Molecular and cellular endocrinology, 2010, Jul-29, Volume: 323, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Calcium; Cell Death; Cytokines; Diazoxide; Gene Expression; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Keto Acids; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Potassium Channels; Probucol; Tolbutamide

2010